Margaret Foti on Cancer Research

Over the past few decades, we have made significant progress against many forms of cancer. Today, there are nearly 14 million cancer survivors living in the United States, 15 percent of whom were diagnosed 20 or more years ago. There have also been more than 1 million fewer cancer deaths since the early 1990s as a result of declining death rates from cancer. However, in spite of the progress, cancer, which is a collective term to describe more than 200 different diseases, remains the second most common cause of disease-related death in the U.S., according to the AACR Cancer Progress Report 2013. The American Association for Cancer Research (AACR) supports the need for ongoing research and the translation of scientific discoveries into new and better ways to prevent, detect, diagnose, and treat cancer. To this end, we have partnered with the Personalized Medicine Coalition (PMC) and Feinstein Kean Healthcare (FKH) on the “Turning the Tide Against Cancer Through Sustained Medical Innovation” initiative with the goal of fostering a national dialogue on how to sustain innovation in cancer research and care in an environment of intense pressure to contain rising health care costs.  A recent article published in Clinical Cancer Research and authored by members of the initiative’s advisory committee, examines the themes that have emerged from these discussions. A key issue has been the need to support the development of patient-centered cancer research and care. Patient engag...
Source: PHRMA - Category: Pharmaceuticals Authors: Source Type: news